<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Crescita Therapeutics Inc — News on 6ix</title>
<link>https://6ix.com/company/crescita-therapeutics-inc</link>
<description>Latest news and press releases for Crescita Therapeutics Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 23:13:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/crescita-therapeutics-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f84d78dffbe2df1306d1.webp</url>
<title>Crescita Therapeutics Inc</title>
<link>https://6ix.com/company/crescita-therapeutics-inc</link>
</image>
<item>
<title>Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-announces-filing-and-mailing-of-special-meeting-materials-and-receipt-of-interim-order-in-respect-of-arrangement-with-clinactiv-holdings</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-announces-filing-and-mailing-of-special-meeting-materials-and-receipt-of-interim-order-in-respect-of-arrangement-with-clinactiv-holdings</guid>
<pubDate>Wed, 22 Apr 2026 23:13:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (&#x201C; Crescita &#x201D; or th...</description>
</item>
<item>
<title>Crescita Reports Q4 and Fiscal 2025 Results</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-q4-and-fiscal-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-q4-and-fiscal-2025-results</guid>
<pubDate>Tue, 31 Mar 2026 11:30:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (&#x201C;Crescita&#x201D; or th...</description>
</item>
<item>
<title>Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-announces-definitive-agreement-to-be-acquired-by-clinactiv-holdings-in-an-all-cash-transaction-at-a-significant-premium</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-announces-definitive-agreement-to-be-acquired-by-clinactiv-holdings-in-an-all-cash-transaction-at-a-significant-premium</guid>
<pubDate>Mon, 16 Mar 2026 11:30:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (&#x201C; Crescita &#x201D; or th...</description>
</item>
<item>
<title>Crescita Reports Third Quarter 2025 Results</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-third-quarter-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-third-quarter-2025-results</guid>
<pubDate>Wed, 05 Nov 2025 12:30:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (&#x201C;Crescita&#x201D; or th...</description>
</item>
<item>
<title>Crescita Reports Second Quarter 2025 Results</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-second-quarter-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-second-quarter-2025-results</guid>
<pubDate>Wed, 06 Aug 2025 12:00:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (&#x201C;Crescita&#x201D; or th...</description>
</item>
<item>
<title>Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-the-results-of-its-annual-general-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-the-results-of-its-annual-general-and-special-meeting-of-shareholders</guid>
<pubDate>Thu, 05 Jun 2025 12:17:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (&#x201C;Crescita&#x201D; or th...</description>
</item>
<item>
<title>Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-mutual-termination-122900283</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-mutual-termination-122900283</guid>
<pubDate>Fri, 23 May 2025 12:29:00 GMT</pubDate>
<description>LAVAL, Quebec, May 23, 2025--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities, today announced that it has, by mutual agreement, terminated its commercialization and development license agreement with CROMA Pharma GmbH ("Croma"), that granted Croma exclusive rights to market Pliaglis® in Germany, the United Kingdom, Ireland, Switzerla</description>
</item>
<item>
<title>Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis&#xAE;</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-mutual-termination-of-licensing-agreement-with-croma-pharma-gmbh-for-pliaglisandxae</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-mutual-termination-of-licensing-agreement-with-croma-pharma-gmbh-for-pliaglisandxae</guid>
<pubDate>Fri, 23 May 2025 12:29:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (&#x201C; Crescita &#x201D;...</description>
</item>
<item>
<title>Crescita Reports First Quarter 2025 Results</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-first-quarter-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-first-quarter-2025-results</guid>
<pubDate>Wed, 14 May 2025 11:35:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (&#x201C;Crescita&#x201D; or th...</description>
</item>
<item>
<title>Crescita Reports Q4 and Fiscal 2024 Results</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-q4-and-fiscal-2024-results</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-q4-and-fiscal-2024-results</guid>
<pubDate>Tue, 18 Mar 2025 11:30:00 GMT</pubDate>
<description>Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (&#x201C;Crescita&#x201D; or th...</description>
</item>
<item>
<title>Croma-Pharma: Launch of topical anaesthetic Pliaglis&#xAE; in Europe</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/croma-pharma-launch-of-topical-anaesthetic-pliaglisandxae-in-europe</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/croma-pharma-launch-of-topical-anaesthetic-pliaglisandxae-in-europe</guid>
<pubDate>Thu, 01 Jun 2023 09:00:00 GMT</pubDate>
<description>Croma-Pharma: Launch of topical anaesthetic Pliaglis&#xAE; in Europe Canada NewsWire ...</description>
</item>
<item>
<title>Crescita Announces Filing of New Medical Device License</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-announces-filing-of-new-medical-device-license</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-announces-filing-of-new-medical-device-license</guid>
<pubDate>Thu, 21 Jan 2021 12:30:00 GMT</pubDate>
<description>Crescita Announces Filing of New Medical Device License Canada NewsWire ...</description>
</item>
<item>
<title>Crescita Therapeutics Announces Approval of Normal Course Issuer Bid</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-approval-of-normal-course-issuer-bid</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-approval-of-normal-course-issuer-bid</guid>
<pubDate>Thu, 26 Nov 2020 12:30:00 GMT</pubDate>
<description>Crescita Therapeutics Announces Approval of Normal Course Issuer Bid Canada New...</description>
</item>
<item>
<title>Crescita Reports Third Quarter 2020 Results</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-third-quarter-2020-results</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-third-quarter-2020-results</guid>
<pubDate>Thu, 12 Nov 2020 12:30:00 GMT</pubDate>
<description>Crescita Reports Third Quarter 2020 Results Canada NewsWire LAVAL, QC, Nov....</description>
</item>
<item>
<title>Crescita Announces Licensing Agreement for Pliaglis&#xAE; in China</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-announces-licensing-agreement-for-pliaglisandxae-in-china</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-announces-licensing-agreement-for-pliaglisandxae-in-china</guid>
<pubDate>Thu, 05 Nov 2020 12:30:00 GMT</pubDate>
<description>Crescita Announces Licensing Agreement for Pliaglis&#xAE; in China Canada NewsW...</description>
</item>
<item>
<title>Crescita Reports Second Quarter 2020 Results</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-second-quarter-2020-results</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-second-quarter-2020-results</guid>
<pubDate>Wed, 12 Aug 2020 11:30:00 GMT</pubDate>
<description>Crescita Reports Second Quarter 2020 Results Canada NewsWire LAVAL, QC, Aug. 12,...</description>
</item>
<item>
<title>Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis&#xAE; U.S. Licensing Agreement</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-to-receive-one-time-cash-payment-following-amendment-to-pliaglisandxae-us-licensing-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-to-receive-one-time-cash-payment-following-amendment-to-pliaglisandxae-us-licensing-agreement</guid>
<pubDate>Tue, 28 Jul 2020 11:30:00 GMT</pubDate>
<description>Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis&#xAE; U.S. Licen...</description>
</item>
<item>
<title>Crescita Reports First Quarter 2020 Results</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-first-quarter-2020-results</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-reports-first-quarter-2020-results</guid>
<pubDate>Wed, 27 May 2020 11:30:00 GMT</pubDate>
<description>Crescita Reports First Quarter 2020 Results Canada NewsWire LAVAL, QC, May 27, 2...</description>
</item>
<item>
<title>Crescita Therapeutics Announces the Results of its Annual General Meeting of Shareholders</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-the-results-of-its-annual-general-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-the-results-of-its-annual-general-meeting-of-shareholders</guid>
<pubDate>Thu, 14 May 2020 12:30:00 GMT</pubDate>
<description>Crescita Therapeutics Announces the Results of its Annual General Meeting of Shareholders ...</description>
</item>
<item>
<title>Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19</title>
<link>https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-extension-of-first-quarter-2020-filings-due-to-covid-19</link>
<guid isPermaLink="true">https://6ix.com/company/crescita-therapeutics-inc/news/crescita-therapeutics-announces-extension-of-first-quarter-2020-filings-due-to-covid-19</guid>
<pubDate>Tue, 28 Apr 2020 21:58:00 GMT</pubDate>
<description>Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19 ...</description>
</item>
</channel>
</rss>